Is It Tougher To Conduct Decentralized Trials In The EU? ‘Don’t Fall Prey To Negative Narrative’

A senior EMA official says companies should use “a little imagination” when confronted with EU member state-specific barriers to decentralized trials and not “just freeze in front of the headlights.”

Senior Couple Telehealth Visit
Drug sponsors are keen to deploy more decentralized elements into future trials • Source: Alamy

More from Clinical Trials

More from R&D